Themes / Group
Building · newly observed relationshipLatest completed snapshot · Aug 24 · 16:55 ET

MARKET-DISCOVERED GROUP

Biotechnology · IRON

THE TRADER READShared activity without a clean directional read

Price direction is split across 24 measured members. Capital-flow confirmation is unavailable.

Price breadth21 up · 2 downRelative median unavailable
Capital-flow alignmentUnavailablePrice breadth is not yet confirmed by flow
Activity nowBuilding_pressureActivity score 34/100
Evidence depth0 support daysLow sample—context, not a validated playbook
EVIDENCE CLOCK

What happened, in timestamp order

0 timed events
TIMING READA causal timing read is unavailable because no material member price onset could be timestamped.

No session event has enough timestamp precision to place on the clock.

2 earlier filing context receipts

WED, FEB 25ACAD filing documented shared operating contextproduct pipeline / R&D affecting expense · date precision only

WED, JUL 29IRON filing documented shared operating contextproduct pipeline / R&D affecting expense · date precision only

Headline times and retained activity confirmations are point-in-time evidence. Price order is inferred from aligned 5-minute bars. Filing evidence has date precision only and is context, not an intraday catalyst claim.

01 · WHAT IS HAPPENING

The move, the flow and who is driving it

Price breadth, unusual activity and signed capital flow are separate observations
Price sequence unavailableA timestamped price sequence is unavailable.
RELATIVE CO-MOVEMENT

How the members are behaving together

Session-normalized

Observed intraday paths are not available for this group yet.

02 · WHY IT MATTERS

Why now and where the move could travel

Context and lead/lag links are evidence, not proof of causation or a forecast
WHY NOW

Verified recent context

0 items

No verified recent catalyst is attached to this move. The relationship may be market-led rather than news-led.

WHY THIS GROUP EXISTS

Shared filing context

35/37 members covered

Moderate filing support: the strongest shared 10-Q/K outlook is operating setup (near-term outlook) across ACAD, ALMS, BEAM, CELC, CGON, CLDX, COGT, CRSP, CYTK, DNTH, DYN, EWTX, GPCR, IBRX, IMNM, IRON, KYMR, MAZE, MRNA, NAMS, PCVX, PRAX, PTGX, RCUS, ROIV, RVMD, RYTM, SMMT, SRRK, SYRE, TARS, UTHR, VKTX, VRDN.

product pipeline / R&D affecting expense

“Personnel-related costs increased $5.9 million related to higher research and development headcount, including an increase of $3.1 million in stock-based compensation driven by awards granted under our equity compensation plans.”

IRON 10-Q · 2026-07-30
product pipeline / R&D

“As previously disclosed for the years ended December 31, 2024 and 2023, prior to the adoption of ASU 2023-09, the effective 136 income tax rate differed from the federal statutory income tax rate as follows: Year Ended December 31, 2024 2023 Federal statutory income tax rate 21.0 % 21.0 % State and local income taxes, net of federal income tax effect 6.4 % 8.0 % Research and development tax credits 12.1 % 4.0 % Stock-based compensation 1.3 % 1.3 % Section 162(m) limitation ( 1.6 )% ( 0.8 )% Other ( 0.1 )% 0.1 % Change in deferred tax asset valuation allowance ( 39.4 )% ( 33.6 )% Effective income tax rate ( 0.3 )% 0.0 % The Company’s effective income tax rates for the years ended December 31, 2025, 2024 and 2023 were primarily due to state income tax resulting from interest income.”

IRON 10-K · 2026-02-26
credit / rates affecting interest expense

“This increase of $2.3 million was primarily due to higher interest income driven by larger cash, cash equivalents and marketable securities balances, partially offset by an increase in interest expense associated with our term loan.”

IRON 10-Q · 2025-11-06
CONFIRMATION NETWORK

Outsiders and cross-asset links

0 outsiders confirming
IMVT → SLVInverse historical lead/lag · strength -0.14

Filing-linked outsiders test whether the move is spreading beyond the established cohort.

No high-confidence filing-linked outsiders are available for this group yet.

03 · WHO IS IN IT

Member participation

Unusual activity and daily price direction are shown separately
MRNAIRONIMNMCGONIMVTALMSBEAMRCUSDNTHPRAXPCVXPTGXDYNSRRKVKTXMAZECOGTSYRERYTMCLDXCRSPGPCRROIVVRDN

23/37 active21 rising · 3 falling

MemberUnusual activityToday's moveRead now
MRNAModerna, Inc.
Elevated · 100/100
+14.4%
Active; unclassifiedHistorical role unavailable
IRONDisc Medicine, Inc.
Most unusual · 90/100
+1.8%
Active; unclassifiedHistorical role unavailable
IMNMImmunome, Inc.
Elevated · 43/100
+5.0%
Active; unclassifiedHistorical role unavailable
CGONCG Oncology, Inc.
Elevated · 41/100
+0.9%
Active; unclassifiedHistorical role unavailable
IMVTImmunovant, Inc.
Elevated · 40/100
+0.4%
Active; unclassifiedHistorical role unavailable
ALMSAlumis Inc.
Elevated · 35/100
+4.1%
Active; unclassifiedHistorical role unavailable
BEAMBeam Therapeutics Inc.
Elevated · 33/100
+9.5%
Active; unclassifiedHistorical role unavailable
RCUSArcus Biosciences, Inc.
Elevated · 32/100
+4.5%
Active; unclassifiedHistorical role unavailable
DNTHDianthus Therapeutics, Inc.
Elevated · 32/100
+1.8%
Active; unclassifiedHistorical role unavailable
PRAXPraxis Precision Medicines, Inc.
Elevated · 29/100
+0.1%
Active; unclassifiedHistorical role unavailable
PCVXVaxcyte, Inc.
Elevated · 29/100
-1.1%
Active; unclassifiedHistorical role unavailable
PTGXProtagonist Therapeutics, Inc.
Elevated · 28/100
-2.7%
Active; unclassifiedHistorical role unavailable
DYNDyne Therapeutics, Inc.
Elevated · 26/100
+1.4%
Active; unclassifiedHistorical role unavailable
SRRKScholar Rock Holding Corporation
Elevated · 25/100
-0.0%
Active; unclassifiedHistorical role unavailable
VKTXViking Therapeutics, Inc.
Elevated · 24/100
+2.9%
Active; unclassifiedHistorical role unavailable
MAZEMaze Therapeutics, Inc.
Elevated · 23/100
+2.7%
Active; unclassifiedHistorical role unavailable
COGTCogent Biosciences, Inc.
Elevated · 23/100
+1.6%
Active; unclassifiedHistorical role unavailable
SYRESpyre Therapeutics, Inc.
Elevated · 22/100
+0.6%
Active; unclassifiedHistorical role unavailable
RYTMRhythm Pharmaceuticals, Inc. Common Stock
Elevated · 22/100
+1.7%
Active; unclassifiedHistorical role unavailable
CLDXCelldex Therapeutics, Inc.
Elevated · 22/100
+1.7%
Active; unclassifiedHistorical role unavailable
CRSPCRISPR Therapeutics AG
Elevated · 21/100
+6.6%
Active; unclassifiedHistorical role unavailable
GPCRStructure Therapeutics Inc.
Elevated · 21/100
+1.7%
Active; unclassifiedHistorical role unavailable
ROIVRoivant Sciences Ltd.
Elevated · 19/100
+0.4%
Active; unclassifiedHistorical role unavailable
VRDNViridian Therapeutics, Inc.
Participating · 14/100
+0.8%
Active; unclassifiedHistorical role unavailable
View exact member values
TICKERCompanyRole nowTodayObserved historyTrader interpretation
MRNAModerna, Inc.Participating+14.4%—Price participation is not yet confirmed by per-name flow.
IRONDisc Medicine, Inc.Most unusual+1.8%—Most unusual activity in this snapshot; performance direction may differ.
IMNMImmunome, Inc.Participating+5.0%—Price participation is not yet confirmed by per-name flow.
CGONCG Oncology, Inc.Participating+0.9%—Price participation is not yet confirmed by per-name flow.
IMVTImmunovant, Inc.Participating+0.4%—Price participation is not yet confirmed by per-name flow.
ALMSAlumis Inc.Participating+4.1%—Price participation is not yet confirmed by per-name flow.
BEAMBeam Therapeutics Inc.Participating+9.5%—Price participation is not yet confirmed by per-name flow.
RCUSArcus Biosciences, Inc.Participating+4.5%—Price participation is not yet confirmed by per-name flow.
DNTHDianthus Therapeutics, Inc.Participating+1.8%—Price participation is not yet confirmed by per-name flow.
PRAXPraxis Precision Medicines, Inc.Participating+0.1%—Price participation is not yet confirmed by per-name flow.
PCVXVaxcyte, Inc.Participating-1.1%—Price participation is not yet confirmed by per-name flow.
PTGXProtagonist Therapeutics, Inc.Participating-2.7%—Price participation is not yet confirmed by per-name flow.
DYNDyne Therapeutics, Inc.Participating+1.4%—Price participation is not yet confirmed by per-name flow.
SRRKScholar Rock Holding CorporationParticipating-0.0%—Price participation is not yet confirmed by per-name flow.
VKTXViking Therapeutics, Inc.Participating+2.9%—Price participation is not yet confirmed by per-name flow.
MAZEMaze Therapeutics, Inc.Participating+2.7%—Price participation is not yet confirmed by per-name flow.
COGTCogent Biosciences, Inc.Participating+1.6%—Price participation is not yet confirmed by per-name flow.
SYRESpyre Therapeutics, Inc.Participating+0.6%—Price participation is not yet confirmed by per-name flow.
RYTMRhythm Pharmaceuticals, Inc. Common StockParticipating+1.7%—Price participation is not yet confirmed by per-name flow.
CLDXCelldex Therapeutics, Inc.Participating+1.7%—Price participation is not yet confirmed by per-name flow.
CRSPCRISPR Therapeutics AGParticipating+6.6%—Price participation is not yet confirmed by per-name flow.
GPCRStructure Therapeutics Inc.Participating+1.7%—Price participation is not yet confirmed by per-name flow.
ROIVRoivant Sciences Ltd.Participating+0.4%—Price participation is not yet confirmed by per-name flow.
VRDNViridian Therapeutics, Inc.Participating+0.8%—Price participation is not yet confirmed by per-name flow.

04 · HAS THIS HAPPENED BEFORE

Identity history versus measured outcomes

Structural recurrence is not the same as a validated trading outcome
POINT-IN-TIME LIVE OUTCOMES

Live outcome ledger collecting

0/0 events completed

No completed point-in-time outcome is available yet. New live confirmations are now retained with their exact observation timestamp; statistics appear only after the corresponding candles complete.

No point-in-time live observations have completed yet.
Low structural sample

Only 0 completed episodes across 0 active sessions; treat history as context, not a validated playbook. These episode counts describe recurrence; the outcome ledger above is the only forward-performance evidence.

Structural support0 daysHow often the cohort identity was observed
Completed episodes0Separate periods of broad group activity
Active sessions0Completed session observations, not trades

Historical cohort observations are not available yet.